HOME >> MEDICINE >> NEWS
Estimated costs of treating abnormal fat distribution and metabolic abnormalities in HIV-infected individuals

ibution. Other therapies sometimes used to treat fat maldistribution include recombinant human growth hormone, liposuction or plastic surgery.

In the study, the costs for diagnosing FMMA were estimated to be $128.74 per patient. The total first year costs for diagnosing, treating and managing FMMA range from $410 for insulin resistance to $7,368 for abnormal fat distribution at the back of the neck (a condition sometimes called "buffalo hump"). The second year costs of treating and monitoring each patient range from $115 to $3,895 depending on the symptom being treated.

Treatment algorithms used in the pharmacoeconomic modeling study were developed based on input from the expert panel. Unit costs (reported in 1999 dollars) were obtained for health care resources used to diagnose, treat and monitor HIV patients with FMMA. These included medical procedures, medications, outpatient visits and hospitalizations. Cost estimates for health care resources were based on an extended version of the Medicare Resource Based Relative Value Scale (RBRVS) and Current Procedural Terminology (CPT) codes of the American Medical Association and reflect current treatment patterns. Medication costs were obtained from the Red Book, which lists the average wholesale prices for medications available in the U.S.

"The benefits of Highly Active Antiretroviral Therapy (HAART) have been documented in the literature. HIV patients are experiencing the benefits of therapy with HIV treatments such as protease inhibitors but are also beginning to experience signs and symptoms of FMMA. Thus as patients continue to experience these signs and symptoms, the evaluation of risk factors for the long-term complications may become an essential component of HIV drug therapy selection," said Jacqueline Carranza Rosenzweig, a medical affairs scientist with Glaxo Wellcome.


'"/>

Contact: Bob Szafranski
bszafranski@pcipr.com
312-558-1770
Public Communications Inc.
17-Sep-2000


Page: 1 2

Related medicine news :

1. Mental health service costs offset by savings in other public sectors
2. Whole-body CT screening costs overshadow benefits
3. Business/govt address health care costs and prevention
4. Health care costs higher for children with special health care needs
5. Medicare HMOs fail to control costs of colon surgery in elderly patients
6. ER patients with substance abuse treatment need incur higher health care costs
7. Report finds new model of care can improve quality, lower costs and increase physician efficiency
8. Can poor countries help rich countries contain drug costs?
9. Physical inactivity costs millions in health care expenses
10. Obese patients have higher health care costs than nonobese patients
11. Biopharmaceutical manufacturing efficiencies signal reduced healthcare costs

Post Your Comments:
(Date:3/6/2015)... Follow us on LinkedIn – ... drug refers to testing of absorption, distribution, metabolism, and ... toxicity studies are clubbed together with ADME, it is ... on lowering costs and time during drug development are ... drug development model uses toxicity and efficacy testing in ...
(Date:3/6/2015)... USA (PRWEB) March 06, 2015 Parents ... the fatal reality of substance use disorders. School programs ... to be marginally successful. NOPE, or Narcotics Overdose Prevention ... nationwide, according to Healthline News on Feb. ... illicit and prescription opiate drugs, drug prevention proponents are ...
(Date:3/6/2015)... 06, 2015 Johnson & Johnson and ... on March 5, 2015 in Superior Court in the ... documents, a jury of 12 awarded Mrs. Perry $700,000 ... implanted with an Ethicon TVT Abbrevo plastic sling for ... three women also awarded $5 million in punitive damages. ...
(Date:3/6/2015)... DC (PRWEB) March 06, 2015 Magellan ... nation’s only comprehensive source for key trends and statistics ... spend, medical injectables. Executives from Magellan Rx Management will ... Trend Report: Discover Your Hidden Specialty Drug Spend,” a ... Information Services, Inc. , Specialty drug spend makes up ...
(Date:3/6/2015)... 06, 2015 The Gluten-Free Certification ... Association, is pleased to announce that Dufflet Pastries, ... has expanded their product line of gluten-free treats ... scrumptious and as satisfying as any of their ... and never contains hydrogenated fats or oils, artificial ...
Breaking Medicine News(10 mins):Health News:Growing Need to Reduce Drug Development Costs Drives the Global ADME-Toxicology Testing Market, According to a New Report by Global Industry Analysts, Inc. 2Health News:Growing Need to Reduce Drug Development Costs Drives the Global ADME-Toxicology Testing Market, According to a New Report by Global Industry Analysts, Inc. 3Health News:A Harbor Village Detox Clinical Psychologist Encourages School Programs like NOPE to Positively Impact Awareness of Substance Use Disorders 2Health News:Johnson & Johnson Hit with $5.7 Million Verdict in Pelvic Mesh Trial Announces Matthews & Associates Law Firm 2Health News:Johnson & Johnson Hit with $5.7 Million Verdict in Pelvic Mesh Trial Announces Matthews & Associates Law Firm 3Health News:Atlantic Information Services, Magellan Rx Management Partner on Complimentary Webinar Outlining Key Findings of New Medical Pharmacy Trend Report 2Health News:Dufflet Pastries® Impressive Collection of Brownies, Cakes, Pies and Cakelets® Now Includes a Gluten-Free Line Certified By the GFCP. 2Health News:Dufflet Pastries® Impressive Collection of Brownies, Cakes, Pies and Cakelets® Now Includes a Gluten-Free Line Certified By the GFCP. 3Health News:Dufflet Pastries® Impressive Collection of Brownies, Cakes, Pies and Cakelets® Now Includes a Gluten-Free Line Certified By the GFCP. 4
(Date:3/6/2015)... WILMINGTON, Del. , March 6, 2015 /PRNewswire/ ... Patent and Trademark Office,s publication of U.S. Patent ... Eating Disorder."  The ,249 Patent Application features claimed methods ... may be used to treat Binge Eating Disorder ... "information material," or "flyer or an advertisement," as ...
(Date:3/5/2015)... , March 5, 2015 BioLineRx (NASDAQ: ... biopharmaceutical company dedicated to identifying, in-licensing and developing ... commenced an underwritten public offering of American Depositary ... Ordinary Shares. All of the ADSs in the ... JMP Securities is acting as sole ...
(Date:3/5/2015)... 5, 2015  IRIDEX Corporation (Nasdaq: IRIX ) ... ended January 3, 2015.  , Revenues were $11.8 ... the Company and up 11% from $10.6 million in the ... a record, up 12% from $38.3 million in 2013. ... up from 48.6% in the fourth quarter of the prior ...
Breaking Medicine Technology:Lucerne Biosciences Announces Publication of Claimed Methods for Treating Binge Eating Disorder with Lisdexamfetamine Dimesylate 2BioLineRx Announces Underwritten Public Offering of its American Depositary Shares 2BioLineRx Announces Underwritten Public Offering of its American Depositary Shares 3IRIDEX Reports 2014 Fourth Quarter, Year-End Results 2IRIDEX Reports 2014 Fourth Quarter, Year-End Results 3IRIDEX Reports 2014 Fourth Quarter, Year-End Results 4IRIDEX Reports 2014 Fourth Quarter, Year-End Results 5IRIDEX Reports 2014 Fourth Quarter, Year-End Results 6IRIDEX Reports 2014 Fourth Quarter, Year-End Results 7IRIDEX Reports 2014 Fourth Quarter, Year-End Results 8
Cached News: